Diabetic Nephropathy: Pathogenesis and Management

Zohreh Rahimi

doi:10.22110/jkums.v20i3.3323

Outline

Abstract
References
Copyright

https://doi.org/10.22110/jkums.v20i3.3323

Diabetic Nephropathy: Pathogenesis and Management

Authors

Zohreh Rahimi^1,*

1Medical Biology Research Center, Dept. of Clinical Biochemistry, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran

*Corresponding Author: Corresponding author: Zohreh Rahimi, Medical Biology Research Center, Dept. of Clinical Biochemistry, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran, Tel: +98 8334274882 Email: [email protected]

Journal of Kermanshah University of Medical Sciences:Vol. 20, issue 3; e69669

Published online:Dec 19, 2016

Article type:Review Article

Received:Aug 30, 2016

Accepted:Sep 27, 2016

How to Cite:Rahimi Z. Diabetic Nephropathy: Pathogenesis and Management. J Kermanshah Univ Med Sci. 2016;20(3):e69669. doi: https://doi.org/10.22110/jkums.v20i3.3323

Abstract

Diabetic nephropathy (DN) is a major microvascular complication of diabetes mellitus and is the leading cause of end-stage renal disease (ESRD). Genetic, metabolic, systemic, and renal hemodynamic factors are involved in the pathogenesis of DN. Advanced glycation end products (AGEs), hypertension, oxidative stress, inflammation, and genetic susceptibility are risk factors for susceptibility to DN and its development. Management approaches of DN are based on the inhibitors of some components of the renin angiotensin aldosterone system (RAAS), AGEs, and protein kinase C (PKC) and combined antioxidants therapy with anti-inflammatory agents. The present review looks at some mechanisms involved in DN and its progression and also management approaches according to the inhibition of the risk factors of the disease.

KeywordsDiabetic

Fulltext

References

1.
The references of this article is available on PDF.

Copyright

© 2016, Journal of Kermanshah University of Medical Sciences. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

8

Jan

2022

Evaluating the Risk Factors of Development and Progression of Diabetic Retinopathy: A Review Study

Seyed Ahmad Rasoulinejad

PDF

Rasoulinejad SA. Evaluating the Risk Factors of Development and Progression of Diabetic Retinopathy: A Review Study. Shiraz E-Med J. 2022;23(5):e117171. doi: https://doi.org/10.5812/semj.117171

12

Sep

2014

Metformin and Diabetic Kidney Disease: A Mini-Review on Recent Findings

Hamid Nasri,

Mahmoud Rafieian-Kopaei

PDF

Nasri H, Rafieian-Kopaei M. Metformin and Diabetic Kidney Disease: A Mini-Review on Recent Findings. Inn J Pediatr. 2014;24(5):. doi:

16

Sep

2024

Prevalence, Incidence, and Risk Factors of Nephropathy in Patients with Prediabetes: Family History of Diabetes Mellitus Is Not Associated with Increased Risk of Nephropathy

Shokoufeh Abbasi,

Masoud Amini,

Sahar Vahdat,

Ashraf Aminorroaya,

Mojgan Mortazavi,

Fatemeh Azimi

PDF

Abbasi S, Amini M, Vahdat S, Aminorroaya A, Mortazavi M, et al. Prevalence, Incidence, and Risk Factors of Nephropathy in Patients with Prediabetes: Family History of Diabetes Mellitus Is Not Associated with Increased Risk of Nephropathy. Jundishapur J Chronic Dis Care. 2024;13(4):e142750. doi: https://doi.org/10.5812/jjcdc-142750

31

Jan

2006

Prevalence and Risk Factors of Microalbuminuria in Type 2 Diabetic Patients in a Diabetic Clinic of Ardabil-Iran

M Iranparvar Alamdari,

N Aminisani,

B Bashardoost,

SM Shamshirgaran,

M Khodamoradzadeh,

M Shokrabadi

,et al.

PDF

Iranparvar Alamdari M, Aminisani N, Bashardoost B, Shamshirgaran S, Khodamoradzadeh M, et al. Prevalence and Risk Factors of Microalbuminuria in Type 2 Diabetic Patients in a Diabetic Clinic of Ardabil-Iran. Int J Endocrinol Metab. 2006;4(1):. doi:

31

Oct

2005